ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Cash Flow
Eloxx Pharmaceuticals, Inc. (ELOX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -4.8 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.6 | -9.9 | -9.5 | -9.7 | -6.9 | -6.8 | -2.1 | -3.5 | 1.2 | -1.8 | -5.5 | -4.8 | |
| 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | – | – | – | – | |
| – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.2 | 0.2 | 0.6 | 0.0 | -0.4 | -1.9 | 1.4 | -0.3 | 2.6 | 0.0 | -1.7 | -0.1 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | – | – | – | – | |
| – | – | – | – | – | – | – | – | -0.9 | 1.9 | 0.0 | 0.0 | |
| 3.4 | -0.2 | 7.0 | – | 1.5 | -7.5 | 1.4 | 3.7 | -0.9 | 1.9 | 7.0 | 60 | |
| -4.3 | -10 | -2.5 | -9.8 | -5.5 | -14 | -0.6 | 0.5 | 0.3 | 0.1 | 1.4 | 56 | |
| -7.7 | -10.0 | -9.5 | -9.8 | -7.0 | -6.8 | -2.1 | -3.5 | 1.2 | -1.8 | -5.5 | -4.8 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.